BTS
BLUE

BB&T Securities’s bluebird bio BLUE Stock Holding History

BB&T Securities’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-196
Closed -$370K – 1486
2018
Q3 		$370K Sell
196
-102
-34% -$211K ﹤0.01% 1229
2018
Q2 		$605K Buy
+298
New +$679K 0.01% 999
2018
Q1 		– Sell
-242
Closed -$557K – 1507
2017
Q4 		$557K Buy
242
+4
+2% +$8.12K 0.01% 959
2017
Q3 		$423K Buy
238
+4
+2% +$5.59K 0.01% 1031
2017
Q2 		$318K Buy
+234
New +$282K ﹤0.01% 1125

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB&T Securities's BLUE Position: Q4 2018 in Review

BB&T Securities sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 196 shares — an estimated $370K sold.

BB&T Securities first reported a position in BLUE in Q2 2017 and held it in 5 quarters. The position peaked at $605K in Q2 2018. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

  • BB&T Securities reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
  • BB&T Securities sold 196 bluebird bio shares in Q4 2018, an estimated $370K.
  • BB&T Securities first reported a position in bluebird bio in Q2 2017 and held it in 5 quarters.
  • BB&T Securities's bluebird bio position peaked at $605K in Q2 2018.
  • 251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on BB&T Securities's 13F filing for Q4 2018, filed 4 Feb 2019.